Search results
Showing 1606 to 1620 of 7712 results
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer (TA632)
Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer in adults who have residual invasive disease in the breast or lymph nodes after neoadjuvant taxane-based and HER2-targeted therapy.
Evidence-based recommendations on osimertinib (Tagrisso) for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer in adults after complete tumour resection.
Evidence-based recommendations on tucatinib (TUKYSA) for HER2-positive locally advanced or metastatic breast cancer in adults after 2 or more anti-HER2 treatment therapies.
In development [GID-QS10182] Expected publication date: 05 February 2025
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension
In development [GID-IPG10299] Expected publication date: 05 February 2025
In development [GID-IPG10392] Expected publication date: 05 February 2025
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
In development [GID-IPG10391] Expected publication date: 05 February 2025
In development [GID-TA11263] Expected publication date: 05 February 2025
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907]
In development [GID-TA10784] Expected publication date: 05 February 2025
In development [GID-TA11514] Expected publication date: 05 February 2025
Masitinib with riluzole for treating amyotrophic lateral sclerosis TS ID 10728
Awaiting development [GID-TA11071] Expected publication date: TBC
Evidence-based recommendations on AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images
Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G)
Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the